Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026
Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026
As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised size of $2 billion by 2026, growing at a CAGR of 16.9%, according to the "Global Cannabis Beverages Industry" report issued on Friday by Reportlinker.com an AI-based award-winning market research solution.
随着新冠肺炎大流行的继续，预计到2026年，全球大麻饮料市场预计到2026年将达到20亿美元的修正规模，年复合增长率为16.9%。2020年，全球大麻饮料市场估计为7.998亿美元“全球大麻饮料行业”星期五发表的报告，由Reportlinker.com基于人工智能的屡获殊荣的市场研究解决方案。
According to the report, the alcoholic segment is readjusted to a revised 15.7% CAGR for the next 7-year period. Meanwhile, the non-alcoholic segment is projected to grow at a 17.5% CAGR to reach$1.6 billion by 2026.
根据这份报告，酒类部门在未来7年内将重新调整为修订后的15.7%的复合年增长率。与此同时，非酒精部分预计将以17.5%的复合年增长率增长，到2026年将达到16亿美元。
"Non-alcoholic cannabis beverages dominate the market and are also expected to register strong growth, mainly supported by growing demand from female and new customers, especially millennials, and also rising interest in wellness drinks among customers. Cannabis-infused alcoholic beverages are also gaining strong popularity, given their capability to offer the alcohol effect, but with health advantages and no calories. They are mainly used by people who consume cannabis as well as alcohol," states the report.
报告称：“非酒精大麻饮料在市场上占据主导地位，预计也将实现强劲增长，这主要得益于女性和新客户，特别是千禧一代对健康饮料不断增长的需求，以及消费者对健康饮料日益浓厚的兴趣。注入大麻的酒精饮料也越来越受欢迎，因为它们具有酒精效应，但对健康有好处，而且不含卡路里。它们主要由吸食大麻和饮酒的人使用，”该报告称，“非酒精大麻饮料在市场上占据主导地位，预计也将实现强劲增长，这主要得益于女性和新客户，尤其是千禧一代，以及消费者对健康饮料的兴趣与日俱增。”
The U.S. market is estimated at $649.1 million in 2021 and "accounts for a 70.9% share in the global market." The report noted that "Guam, Puerto Rico, the US Virgin Islands, District of Columbia, and 33 States have granted approval to medical cannabis programs (publicly available), which led to the introduction of many cannabis drinks. Further, 13 states in the country permit the usage of high CBD and low THC products for medical uses, which has resulted in strong adoption of CBD infused cannabis drinks."
据估计，2021年美国市场规模为6.491亿美元，“在全球市场中占有70.9%的份额.”报告指出，“关岛、波多黎各、美属维尔京群岛、哥伦比亚特区和33个州已经批准了医用大麻项目(公开提供)，这导致了许多大麻饮料的推出。此外，该国有13个州允许将高CBD和低THC产品用于医疗用途，这导致了CBD注入大麻饮料的大量采用。”
Among the other noteworthy geographic markets are Canada and Europe, each forecast to grow at 16.7% and 16.1% by 2026. Asia-Pacific is forecast to reach an estimated market size of $146.7 million in 2026 trailing a CAGR of 14.2% through the analysis period.
其他值得注意的地理市场包括加拿大和欧洲，预计到2026年，这两个市场的增长率分别为16.7%和16.1%。预计2026年亚太地区的市场规模预计将达到1.467亿美元，落后于分析期间14.2%的复合年增长率。
By Component, THC Segment to Reach $1.2 Billion by 2026
按组件划分，THC细分市场到2026年将达到12亿美元
According to the report, the demand for cannabis beverages infused with THC is being supported by the growing consumption among adults looking for "euphoria" and "therapeutic benefits." In the global THC segment, the U.S., Canada and Europe will drive a 16.2% CAGR. These regional markets accounting for a combined market size of $422.5 million in 2020 will reach a projected size of $1.2 billion by 2026. The market in Asia-Pacific is forecast to reach $76.6 million by 2026.
根据这份报告，对注入THC的大麻饮料的需求得到了成年人日益增长的消费的支持，这些成年人寻求“快感”和“治疗益处”。在全球THC领域，美国、加拿大和欧洲将推动16.2%的复合年增长率。到2020年，这些地区市场的总市场规模将达到4.225亿美元，预计到2026年将达到12亿美元。预计到2026年，亚太地区的市场规模将达到7660万美元。
Some of the "Select Competitors" featured in the report include Tilray Inc. (NASDAQ:TLRY), Aurora Cannabis Inc. (TSE: ACB), CannTrust Holdings Inc. (OTC:CNTTQ), Canopy Growth Corporation (TSE: WEED), Cronos Group Inc. (TSE: CRON), GW Pharmaceuticals plc (NASDAQ:JAZZ), HEXO Operations Inc. (NASDAQ:HEXO), and Organigram Holdings Inc. (TSE: OGI).
报告中提到的一些“精选竞争对手”包括Tilray Inc.(纳斯达克：TLRY)，奥罗拉大麻公司(Aurora Cannabis Inc.)(TSE：ACB)，CannTrust Holdings Inc.(场外交易代码：CNTTQ)，树冠生长公司(谢霆锋：杂草)，克罗诺斯集团(Cronos Group Inc.)(谢霆锋：Cron)，GW制药公司(纳斯达克：爵士乐)，HEXO运营公司(纳斯达克：HEXO)，以及OrganiGram控股公司(谢霆锋：OGI)。
Photo by pariwat pannium on Unsplash.
照片由Pariwat pannium在Unspash上拍摄。